Trade Mark Journal No.2026/041 9 October 2026
UK00004448658 21 September 2026 (5,42)
Novarrow
- Class 5
- Therapeutic pharmaceutical preparations; Medicinal preparations for the treatment and prevention of diseases and medical conditions; Gene therapy preparations for medical purposes; Cell therapy preparations for medical purposes; Pharmaceutical and biological preparations for clinical and therapeutic use; Biological preparations for the treatment of genetic disorders; Personalised therapeutic preparations for medical use; Pharmaceutical and biological preparations for the treatment of rare diseases; Small molecule pharmaceutical preparations; Pharmaceutical preparations for the treatment of Shwachman-Diamond syndrome; Biological preparations for the treatment of Shwachman-Diamond syndrome.
- Class 42
- Consultancy relating to research and development in the field of therapeutics; Non downloadable software for drug development; SaaS for research and development; Artificial Intelligence solutions drug development; Medical and pharmaceutical research; Biotechnology research; Biological research; Biomedical research services; Scientific research relating to therapeutics, pharmaceuticals, biologics, cell therapies, and gene therapies; Drug discovery services; Pharmaceutical research and development; Research and development of pharmaceutical preparations; Research and development of biological preparations for medical use; Clinical research services; Clinical trial design, management, monitoring, and analysis; Conducting scientific studies and clinical studies; Laboratory research services; Laboratory testing services; Scientific testing and analysis services; Scientific investigations for medical and pharmaceutical purposes; Development of therapeutic products and treatment technologies; Research relating to genetics, genomics, proteomics, molecular biology, and bioinformatics; Cell engineering research; Gene editing research; Development and testing of cell therapies and gene therapies; Research in the field of personalised medicine and precision medicine; Scientific analysis and data analysis services; Research and development in the field of medicinal chemistry; Research and development in the field of structural biology; Scientific research in the field of structural biology; Scientific research relating to rare diseases; Scientific research relating to Shwachman-Diamond syndrome; Preclinical research and testing; Clinical trial planning and consultancy.
Maxim Rossmann
Representative: Basck Limited